Trial Details
RECRUITINGBasic Information
| Clinical ID | c354 |
|---|---|
| Identifier | NCT06721962 |
| Trial Title | Treatment of Moderate to Severe Refractory Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohns Disease |
| Interventions | BIOLOGICAL: TRX103|DRUG: Cyclophosphamide |
Participant Information
| Sponsor | Tr1X, Inc. |
|---|---|
| City | Scottsdale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-05-05 |
|---|---|
| Primary Completion Date | 2026-01-30 |
| Completion Date | 2027-01-30 |